Pancreatic Cancer Research

ResearcherChinese PLA General HospitalActive in the last 2 years

Lincheng Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7688-2749; OpenAlex author ID A5101527803. Sources: OpenAlex.

Their work

Papers
8 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2021: 1 paper · 2022: 3 papers · 2023: 2 papers · 2024: none · 2025: 2 papers

Papers 8

  1. A lipid metabolism related gene signature predicts postoperative recurrence in pancreatic cancer through multicenter cohort validation. Co-author DOI 10.1038/s41598-025-96855-1↗
  2. Integrated analysis of polytranscriptomics reveals TNFSF ligand genes in pancreatic cancer prognosis and immune regulation. First author DOI 10.1186/s12865-025-00733-4↗
  3. DCLRE1B promotes tumor progression and predicts immunotherapy response through METTL3-mediated m6A modification in pancreatic cancer. Co-author DOI 10.1186/s12885-023-11524-8↗
  4. Hypoxia-induced Long Non-coding RNA LSAMP-AS1 Regulates ceRNA Network to Predict Prognosis for Pancreatic Cancer. Co-author DOI 10.2174/1386207326666230314112238↗
  5. Molecular subtyping based on TRP family and prognostic assessment for TRP-associated lncRNAs in pancreatic adenocarcinoma. Co-author DOI 10.1186/s12876-022-02552-y↗
  6. Identification of CKS1B as a prognostic indicator and a predictive marker for immunotherapy in pancreatic cancer. Co-author DOI 10.3389/fimmu.2022.1052768↗
  7. Analysis of Pyroptosis-Related Signature for Predicting Prognosis and Tumor Immune Microenvironment in Pancreatic Cancer. Co-author DOI 10.3389/fonc.2022.770005↗
  8. Up-regulation of S100P predicts the poor long-term survival and construction of prognostic signature for survival and immunotherapy in patients with pancreatic… First author DOI 10.1080/21655979.2021.1992331↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhaoda Deng · 7 shared papers, 2022–2025 · strength 1.60
  2. Rong Liu · 6 shared papers, 2021–2023 · strength 1.12
  3. Wenbo Zou · 4 shared papers, 2021–2022 · strength 0.67
  4. Fei Wang · 2 shared papers, 2021–2023 · strength 0.35
  5. Rong Liu · 1 shared paper, 2025 · strength 0.33
  6. Rong Liu · 1 shared paper, 2025 · strength 0.30
  7. Wenbo Zou · 1 shared paper, 2023 · strength 0.24
  8. Zhiming Zhao · 1 shared paper, 2023 · strength 0.20
  9. Gong Zhang · 1 shared paper, 2022 · strength 0.17
  10. Jing Wang · 1 shared paper, 2022 · strength 0.15
  11. Zizheng Wang · 1 shared paper, 2021 · strength 0.15
  12. Minggen Hu · 1 shared paper, 2021 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.